Loading…
Health In Tech, Inc. is projected to decline to $0.9146 by 2027, a -2% move from its current price of $0.9347. HIT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.8816 | $0.9346 | $0.9909 | -0.01% |
| May 30 | $0.8605 | $0.9346 | $1.02 | -0.01% |
| May 31 | $0.8446 | $0.9345 | $1.03 | -0.02% |
| Jun 1 | $0.8314 | $0.9345 | $1.05 | -0.03% |
| Jun 2 | $0.82 | $0.9344 | $1.06 | -0.03% |
| Jun 3 | $0.8098 | $0.9343 | $1.08 | -0.04% |
| Jun 4 | $0.8005 | $0.9343 | $1.09 | -0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8005 | $0.9343 | $1.09 | -0.04% |
| Week 2 | $0.7505 | $0.9339 | $1.16 | -0.09% |
| Week 3 | $0.7143 | $0.9335 | $1.22 | -0.13% |
| Week 4 | $0.685 | $0.9331 | $1.27 | -0.18% |
| Week 5 | $0.6602 | $0.9327 | $1.32 | -0.22% |
| Week 6 | $0.6385 | $0.9322 | $1.36 | -0.26% |
| Week 7 | $0.6191 | $0.9318 | $1.40 | -0.31% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a program manager specializing in customized self-funded benefits plans for businesses; ICE is, an MGU, which specializes in underwriting and providing administrative functions on behalf of stop loss carriers; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small and medium sized employers.
It also provides health intelligence (HI) cards to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.
Health In Tech, Inc. (HIT) currently trades at $0.8985 per share and has a market capitalization of $58.88M. The company is ranked 4514 by market cap and operates within the Technology category.
A major floor 65.8% below — a decisive break under it would weaken the trend.
The nearest floor, 7.3% below — buyers have tended to step in here.
The nearest ceiling, 84.0% above — a clean break opens room to run.
A major ceiling 117.2% above — clearing it would confirm fresh momentum.
Key HIT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HIT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.9266 | Buy | $0.9464 | Sell |
| MA 10 | $1.05 | Sell | $1.05 | Sell |
| MA 20 | $1.28 | Sell | $1.20 | Sell |
| MA 50 | $1.44 | Sell | $1.36 | Sell |
| MA 100 | $1.42 | Sell | $1.49 | Sell |
| MA 200 | $1.96 | Sell | $1.78 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 29.85 | Buy |
| Stoch RSI (14) | 20.35 | Neutral |
| CCI (20) | -90.42 | Neutral |
| Williams %R (14) | -90.20 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | -40.06 | Sell |
| Bollinger %B (20,2) | 0.18 | Neutral |
| Stochastic %K (14) | 9.80 | Buy |
| TRIX (15) | -1.07 | Sell |
| Awesome (5,34) | -0.44 | Sell |
| Ultimate (7,14,28) | 25.39 | Buy |
| Momentum (10) | -0.58 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 0.85 | Buy |
| ADX (14) | 25.40 | Sell |
| ATR (14) | 0.06 | Info |
The near-term sentiment is NEUTRAL. The RSI(14) is 20, with a 30-day moving average of $1.47 and a 200-day moving average of $1.98.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.866 | $0.9347 | $1.18 | 0% | Neutral | |
| $0.6545 | $0.9146 | $1.38 | -2% | Neutral | |
| $0.5402 | $0.8028 | $1.29 | -14% | Neutral | |
| $0.6752 | $1.06 | $1.79 | +13% | Neutral | |
| $0.9223 | $1.52 | $2.67 | +62% | Bullish | |
| $0.7721 | $1.33 | $2.42 | +42% | Bullish | |
| $0.7071 | $1.27 | $2.39 | +36% | Bullish | |
| $0.7202 | $1.35 | $2.61 | +45% | Bullish | |
| $0.6226 | $1.22 | $2.41 | +30% | Bullish | |
| $0.7852 | $1.60 | $3.24 | +71% | Bullish | |
| $0.7859 | $1.75 | $3.89 | +87% | Bullish | |
| $1.72 | $3.81 | $8.77 | +308% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.866 | $0.9347 | $1.11 | +0.00% |
| June 2026 | $0.80 | $0.9606 | $1.20 | +2.77% |
| July 2026 | $0.7607 | $0.9294 | $1.19 | -3.25% |
| August 2026 | $0.7043 | $0.8723 | $1.14 | -6.15% |
| September 2026 | $0.7197 | $0.9016 | $1.19 | +3.36% |
| October 2026 | $0.7427 | $0.9403 | $1.26 | +4.29% |
| November 2026 | $0.6984 | $0.8925 | $1.21 | -5.08% |
| December 2026 | $0.6648 | $0.8572 | $1.18 | -3.96% |
Click any year to see its month-by-month HIT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, HIT is projected to trade between $0.866 and $1.18, averaging $0.9347 — a potential gain of 0% from today's $0.9347. Price action looks broadly range-bound.
Health In Tech, Inc.'s 2027 outlook centres on $0.9146, within a $0.6545 to $1.38 range. That is -2% versus the projected 2026 average. That marks a -2% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, HIT could reach as high as $1.29, with a base case around $0.8028 and support toward $0.5402 — roughly -14% from $0.9347. Price action looks broadly range-bound.
Expect HIT to range from $0.6752 to $1.79 through 2029. The $1.06 average target implies a +13% move from current prices. That is up +32% on the projected 2028 average. A consolidation phase looks the most probable path here.
The HIT price prediction for 2030 points to an average of $1.52 (low $0.9223, high $2.67) — a potential gain of +62% on today's $0.9347. Momentum favours further upside here.
In 2031, HIT is projected to trade between $0.7721 and $2.42, averaging $1.33 — a potential gain of +42% from today's $0.9347. That is -12% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
Health In Tech, Inc.'s 2032 outlook centres on $1.27, within a $0.7071 to $2.39 range. That is -4% versus the projected 2031 average. That marks a +36% change versus current levels. Momentum favours further upside here.
By 2033, HIT could reach as high as $2.61, with a base case around $1.35 and support toward $0.7202 — roughly +45% from $0.9347. Buyers look set to stay in control over this stretch.
Expect HIT to range from $0.6226 to $2.41 through 2034. The $1.22 average target implies a +30% move from current prices. That is -10% versus the projected 2033 average. Momentum favours further upside here.
The HIT price prediction for 2035 points to an average of $1.60 (low $0.7852, high $3.24) — a potential gain of +71% on today's $0.9347. Buyers look set to stay in control over this stretch.
In 2040, HIT is projected to trade between $0.7859 and $3.89, averaging $1.75 — a potential gain of +87% from today's $0.9347. That is up +9% on the projected 2035 average. Momentum favours further upside here.
Health In Tech, Inc.'s 2050 outlook centres on $3.81, within a $1.72 to $8.77 range. That is up +118% on the projected 2040 average. That marks a +308% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in HIT today (≈ 1,069.861988 HIT) could be worth
$4,081.29
+$3,081.29 (+308%) by 2050 · US Dollar
Based on the average projected HIT price of $3.81 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HITwould be worth at today's price.
$1,000 invested in HIT on May 27, 2025 (≈ 1,485.884149 HIT) would be worth
$1,388.86
+$388.86 (+38.9%) today · 1.39× · US Dollar
Based on a HIT entry price of $0.673 vs. today's $0.9347.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.01 | $925.45 | -7.5% |
| 1 month ago | $1.5 | $623.13 | -37.7% |
| 3 months ago | $1.35 | $692.37 | -30.8% |
| 6 months ago | $1.52 | $614.93 | -38.5% |
| 1 year ago | $0.673 | $1,388.86 | +38.9% |
| All time (1.4y) ago | $5.1 | $183.27 | -81.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HIT forecast.
Our base-case forecast reaches $1.90 around 2050.
Implied market cap at $1.90: $102.3M
The multi-year forecast shows a bullish path into the 2030s and beyond. In 2030, the average price is forecast at $1.39 with a maximum of $2.46, and a return on investment of 55.2 with a bullish sentiment. By 2040, the average is forecast at $1.52 with a maximum of $3.39 and a return on investment of 68.9, still with a bullish sentiment.
In 2050, the average is forecast at $3.37 with a maximum of $7.76 and a return on investment of 275.3, maintaining a bullish sentiment.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.39 and a maximum of $2.46, for a ROI of 55.2 and a bullish sentiment.
The long-term forecast indicates bullish momentum, with an average price of $3.37 and a maximum of $7.76 by 2050 and a ROI of 275.3, though near-term forecasts include a 2028 bear case and other fluctuations.
Yes, the 2030 forecast lists a maximum of $2.46, with an average of $1.39 and a minimum of $0.8449.
Current price is $0.8985 and the market cap is $58.88M.
The 30-day range is from $0.6078 to $1.33.
Health In Tech, Inc. Community Discussion
0Share your Health In Tech, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.